SCHEMBL30867708

SCHEMBL30867708

COC1(c2nccc(C)c2[C@H]2CCN[C@H](C)C2)COC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30867700 0.90
SCHEMBL30867882 0.85 HTR1A (0.36)
SCHEMBL30868059 0.81 SSTR1 (0.36) PLG
SCHEMBL30867883 0.81 TLR8 (0.33)
SCHEMBL30867858 0.77 HTR2A (0.31)
SCHEMBL38654423 0.77 HTR2A (0.31)
SCHEMBL38653853 0.75 PDE10A (0.34) PLG
SCHEMBL30867758 0.73 GPR119 (0.38)
SCHEMBL38653881 0.69 RAF1 (0.32)
SCHEMBL30867920 0.69 GPR119 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598917-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2025-08-13 EP disclosed
WO-2024076674-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 WO disclosed